Important industry news, application updates and new features

Investing in a CTMS: 3 Advantageous Reasons for Small Pipeline

Investing in a CTMS: Three Reasons to Start While Your Study Pipeline is Small

Investing in a CTMS would be a good idea before your study pipeline is full. Purchasing a clinical trial management system at a later time might be a drawback for the success of the research site due to several reasons. There are at least three main benefits of integrating this type of software, while having smaller number of studies.

Justifying the costs 

Small- or mid-sized research sites, might not feel the necessity of using a CTMS. However, having enough studies to justify the costs, might just be a pitfall in foreseeing many opportunities. Investing in a CTMS before the site has more protocols is a strategic business plan, that can secure more studies for your organization faster and easier. Implementing the right system is a step further in creating positive efforts in filling the study pipeline more effectively and in facile manner.

Delivering the needed papers and evidences to sponsors and CROs builds trust that your site is capable of successfully completing a trial. The CTMS helps in managing everything within site’s infrastructure and delivering the needed information to the CRO or/and sponsor. What is more, a good clinical trial management system tracks all study metrics precisely and successively. It can be used as a centralized system, where all documents and information are stored, and therefore allows for continuous monitoring.

Transferring the data

Rolling out a CTMS while having not so many studies reduces data entry duplication as well as end-user overwhelm. One of the big challenges, when investing in a CTMS and integrating it is the data migration. Sites usually need to assign the task to a responsible person or a dedicated team to input all of the existing data. Another option is to pay the CTMS provider to do the work and enter all information associated with current and past trials. Nevertheless, both variants need proper management of time and financial resources.

In other words, purchasing a CTMS with just small number of studies, avoids unnecessary costs associated with the time for the data migration or those associated with payments to the vendor to do the necessary. This also allows the site to establish and adhere to the protocols and practices and get used to working with the system before a pile of work needs to be done.

Making CTMS adoption as simple as possible

Successful implementation of CTMS that fits your organization’s processes and needs might not only be overwhelming but also not an easy task. There are many factors that you should consider when selecting the best system and the right vendor to streamline your operations, and they begin from the functionalities of the system and its user-friendliness. If you are in the beginning of everything and are trying to select a software for the first time, its successful implementation might look like a myth.

When you start implementing a CTMS to your research program for the first time, you should aim at making the user adoption as simple as possible. Starting small, with low number of studies takes the pressure off the team. In addition, they can learn to operate with the system in small steps, so that they can master it better. At the same time, they can stay pertinent to their responsibilities across the study pipeline.

Investing in a CTMS before securing more studies is an advantageous step to consider. It will bring more success to your organization and support you during your growth. The appropriate clinical trial management system can make positive changes to the efficiency of your study operations. It can also build more trust in your sponsors and CROs and eventually attract more new trials.

If you are searching for investing in a CTMS for first implementation, then our clinical trial management system might be the right solution for you. Clinicubes offers integrated solutions for every single process and phase of the trial. In its core, the software is user friendly, centralized and well-built. The system delivers easier way of collecting, retaining and archiving patient and scientific data. Clinical research professionals can also track deadlines, schedule visitations and monitor treatment progress. The system increases the productivity of the clinical research sites and the number of successfully completed trials. It also streamlines the entire clinical trial process, making the CTMS implementation successful and an easily attainable goal.

You can find the PDF version of the article here: Investing in a CTMS